文献速递关节外科

多次关节腔内注射同种异体骨髓间充质干细胞可能改善兔膝骨关节炎病变

Multiple intra-articular injections of allogeneic bone marrow-derived stem cells potentially improve knee lesions resulting from surgically induced osteoarthritis: an animal study.
PubMed 文献 · Bone Joint J · 2019-01-01

研究在9月龄以上日本白兔双侧前交叉韧带切断2个月后的骨关节炎模型中,向膝关节注射磷酸盐缓冲液或1×10^6个间充质干细胞,分单次或连续三次给药;2个月后评估软骨与半月板。多次注射组OARSI评分显著优于其他组,软骨与半月板大体及组织学表现改善;单次注射不足以恢复骨关节炎关节状态。

要点

  • 单次注射间充质干细胞不足以恢复骨关节炎关节状态
  • 多次注射组OARSI评分显著优于单次注射组与对照组
  • 多次注射组软骨基质染色强度与软骨细胞分布良好

核心结论

  • 单次注射间充质干细胞不足以恢复骨关节炎关节状态,而多次注射间充质干细胞具有替代丢失细胞及减轻炎症的能力。

研究设计与样本

  • 动物研究:9月龄以上日本白兔双侧前交叉韧带切断2个月后,膝关节注射磷酸盐缓冲液或1×10^6个间充质干细胞,分单次或连续三次给药,2个月后评估关节软骨与半月板。

主要发现

  • 对照组可见典型进展性退变;单次注射组骨关节炎改变减轻但仍存在,尤其是内侧间室出现软骨纤维化、内侧平台骨赘形成及半月板纵行撕裂。
  • 多次注射组关节软骨与半月板的光滑度和质地改善;多次注射组各软骨区基质染色强度与软骨细胞分布良好。
  • OARSI评分多次注射组显著优于其他组;免疫组化显示单次注射组内侧股骨髁表层存在I型胶原,多次注射组II型胶原较单次注射组更明显。

关键数值与推荐

  • 骨关节炎模型建立方式为双侧前交叉韧带切断,2个月后注射。
  • 注射细胞数为1×10^6个间充质干细胞,分单次或连续三次给药。
  • OARSI评分:多次注射组显著优于其他组。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Mesenchymal stem cells (MSCs) have several properties that may support their use as an early treatment option for osteoarthritis (OA). This study investigated the role of multiple injections of allogeneic bone marrow-derived stem cells (BMSCs) to alleviate the progression of osteoarthritic changes in the various structures of the mature rabbit knee in an anterior cruciate ligament (ACL)-deficient OA model. MATERIALS AND METHODS: Two months after bilateral section of the ACL of Japanese white rabbits aged nine months or more, either phosphate buffered saline (PBS) or 1 x 106 MSCs were injected into the knee joint in single or three consecutive doses. After two months, the articular cartilage and meniscus were assessed macroscopically, histologically, and immunohistochemically using collagen I and II. RESULTS: Within the PBS injection (control group), typical progressive degenerative changes were revealed in the various knee structures. In the single MSC injection (single group), osteoarthritic changes were attenuated, but still appeared, especially in the medial compartments involving fibrillation of the articular cartilage, osteophyte formation in the medial plateau, and longitudinal tear of the meniscus. In the multiple-injections group, the smoothness and texture of the articular cartilage and meniscus were improved. Histologically, absence or reduction in matrix staining and cellularity were noticeable in the control and single-injection groups, respectively, in contrast to the multiple-injections group, which showed good intensity of matrix staining and chondrocyte distribution in the various cartilage zones. Osteoarthritis Research Society International (OARSI) scoring showed significantly better results in the multiple-injections group than in the other groups. Immunohistochemically, collagen I existed superficially in the medial femoral condyle in the single group, while collagen II was more evident in the multiple-injections group than the single-injection group. CONCLUSION: A single injection of MSCs was not enough to restore the condition of osteoarthritic joints. This is in contrast to multiple injections of MSCs, which had the ability to replace lost cells, as well as reducing inflammation. Cite this article: Bone Joint J 2019;101-B:824-831.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Mahmoud EE, Adachi N, Mawas AS, et al. Multiple intra-articular injections of allogeneic bone marrow-derived stem cells potentially improve knee lesions resulting from surgically induced osteoarthritis: an animal study. Bone Joint J. 2019. PMID: 31256666. doi:10.1302/0301-620X.101B7.BJJ-2018-1532.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。